Fig. 2From: Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort studyCognitive and biomarker changes during 24 months between amyloid-positive SCDs and amyloid-negative SCDs. Dotted line indicates Aβ-SCD and solid line indicates Aβ + SCD * Statistically significant (p < 0.05)Back to article page